NOVATO, Calif., June 20, 2025 - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) has announced the grant of 48,731 restricted stock units to 26 newly hired non-executive officers as part of its Ultragenyx Employment Inducement Plan. The awards, approved by the company's board of directors' compensation committee, are intended as a material inducement for the new employees joining the company. These restricted stock units will vest over a period of four years, with 25% of the shares vesting annually on the anniversary of the grant date, provided the employees remain continuously employed with Ultragenyx.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9469372-en) on June 20, 2025, and is solely responsible for the information contained therein.